Matches in Wikidata for { <http://www.wikidata.org/entity/Q63534767> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q63534767 description "clinical trial" @default.
- Q63534767 description "ensayu clínicu" @default.
- Q63534767 description "klinisch onderzoek" @default.
- Q63534767 description "клінічне випробування" @default.
- Q63534767 name "HR+/HER2- Advanced Breast Cancer and Endocrine Resistance" @default.
- Q63534767 type Item @default.
- Q63534767 label "HR+/HER2- Advanced Breast Cancer and Endocrine Resistance" @default.
- Q63534767 prefLabel "HR+/HER2- Advanced Breast Cancer and Endocrine Resistance" @default.
- Q63534767 P1132 Q63534767-580CABFB-438F-4CF2-AEDA-3024F606B94D @default.
- Q63534767 P1476 Q63534767-775E7C81-7B87-4D45-B3DD-F0F302221993 @default.
- Q63534767 P17 Q63534767-7EEE7203-8403-4F80-A11B-3928191E1026 @default.
- Q63534767 P1813 Q63534767-B2DCA9D8-0DB3-467E-B4C6-7F1824E56900 @default.
- Q63534767 P2899 Q63534767-BAA74996-8F25-46BF-BA64-2FE1FE53EDDE @default.
- Q63534767 P3098 Q63534767-692D3B1F-1DB8-48C6-B71A-20C3404F0160 @default.
- Q63534767 P31 Q63534767-DAE5FC7E-63FC-48D0-898E-244186604BB2 @default.
- Q63534767 P4844 Q63534767-1DE741F3-FD56-4487-A05D-CACCAFF25D42 @default.
- Q63534767 P4844 Q63534767-211F97D1-5430-46A8-9FDC-D2FF9EAB2EAD @default.
- Q63534767 P4844 Q63534767-61BAD146-4143-4589-A439-5F14ECB0926D @default.
- Q63534767 P580 Q63534767-AC43F85C-DA65-4750-AB56-A1C010585C0A @default.
- Q63534767 P582 Q63534767-4677A75D-C420-4B11-A3A6-8E30C4039E4D @default.
- Q63534767 P6099 Q63534767-A4DB152D-FC0F-46E4-BC64-C0D09E2BEE68 @default.
- Q63534767 P6153 Q63534767-067DDE8A-7422-4519-AA0C-9B294C886051 @default.
- Q63534767 P6153 Q63534767-8659C555-1BDB-46DC-9B4A-0AA885232715 @default.
- Q63534767 P6153 Q63534767-BEAF7745-ECBA-4C56-98C3-3752A7FC559C @default.
- Q63534767 P6153 Q63534767-F3E3AE78-CBDC-4886-9424-B37F334BA4D2 @default.
- Q63534767 P8363 Q63534767-8982A6BA-F4E7-4730-BB16-B3FD4A68C1B5 @default.
- Q63534767 P859 Q63534767-C8F46719-75E5-43C9-871B-E2800F3D612F @default.
- Q63534767 P1132 "+196" @default.
- Q63534767 P1476 "A Phase 2, International, Multicenter, Open-labeled, Randomized Trial of PAlbociclib and Fulvestrant vs. Standard Oral Capecitabine In Patients With Hormone Receptor (HR)+ / HER2- Advanced Breast Cancer and Documented Endocrine Resistance" @default.
- Q63534767 P17 Q34 @default.
- Q63534767 P1813 "PASIPHAE" @default.
- Q63534767 P2899 "+18" @default.
- Q63534767 P3098 "NCT03322215" @default.
- Q63534767 P31 Q30612 @default.
- Q63534767 P4844 Q15269707 @default.
- Q63534767 P4844 Q420207 @default.
- Q63534767 P4844 Q5508491 @default.
- Q63534767 P580 "2017-10-24T00:00:00Z" @default.
- Q63534767 P582 "2021-10-31T00:00:00Z" @default.
- Q63534767 P6099 Q42824440 @default.
- Q63534767 P6153 Q185246 @default.
- Q63534767 P6153 Q219564 @default.
- Q63534767 P6153 Q3290496 @default.
- Q63534767 P6153 Q6954137 @default.
- Q63534767 P8363 Q78089383 @default.
- Q63534767 P859 Q41669714 @default.